Clinical trial · Observational
Colour Doppler Flow Imaging in Lacrimal Gland Lesions
Usefulness of Colour Doppler Flow Imaging in the Management of Lacrimal Gland Lesions
NCT02900846CI-TRIAL-00025721GLIRcompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Retrospective medical charts and medical imaging files review of patients suffering from lacrimal fossa lesions who underwent ocular ultrasonography with color flow doppler imaging.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lacrimal Tumor | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Pulsed wave doppler resistance index in tumor vascularization
- timeFrame
- 1 week
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients suffering from lacrimal fossa tumor * Orbital ultrasonography performed, including doppler flow imaging * Histopathological characterization of the tumor obtained after surgical removal Exclusion Criteria: * Absence of histopathological characterization * Absence of documented ultrasound doppler flow imaging
References
Publications (0)
Data not yet available
No reference posted for this study.